Effect of tiplaxtinin (PAI-039), an orally bioavailable PAI-1 antagonist, in a rat model of thrombosis
J. K. HENNAN, G. A. MORGAN, R. E. SWILLO, T. M. ANTRILLI, C. MUGFORD, G. P. VLASUK, S. J. GARDELL, D. L. CRANDALLVolume:
6
Year:
2008
Language:
english
Pages:
1
DOI:
10.1111/j.1538-7836.2008.03063.x
File:
PDF, 288 KB
english, 2008